Back
Protagonist Therapeutics Vs. Impinj Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
30.74
Seasonality Move:
16.08%
Sell
43
PI
Impinj
Last Price:
173.68
Seasonality Move:
17.91%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.74. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Impinj (PI)
is a Sell
Is Impinj a Buy, Sell or Hold?
- The current Impinj [PI] share price is $173.40. The Score for PI is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- PI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 65.8 | Buy |
Chaikin Money Flow: | -378836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.92 - 29.04) | Buy |
Bollinger Bands (100): | (24.71 - 29.41) | Buy |
PI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.23 | Buy |
Relative Strength Index (14 RSI): | 69.26 | Buy |
Chaikin Money Flow: | 204130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.56 - 168.96) | Buy |
Bollinger Bands (100): | (92.91 - 141.39) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.59 | Buy |
20-day SMA: | 27.27 | Buy |
50-day SMA: | 27.76 | Buy |
200-day SMA: | 22.41 | Buy |
8-day EMA: | 29.73 | Buy |
20-day EMA: | 28.24 | Buy |
50-day EMA: | 27.54 | Buy |
200-day EMA: | 24.11 | Buy |
PI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 166.02 | Buy |
20-day SMA: | 156.05 | Buy |
50-day SMA: | 135.82 | Buy |
200-day SMA: | 91.78 | Buy |
8-day EMA: | 167.13 | Buy |
20-day EMA: | 156.75 | Buy |
50-day EMA: | 139.33 | Buy |
200-day EMA: | 107.87 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Impinj Earnings Growth & PI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.48 per share, an increase this year of $1.08 per share, and an increase next year of $0.64 per share.
Protagonist Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Impinj Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |